Padres Trade for Mize at Deadline: A Strikeout Boost With Durability Risk
By Justin Erickson ·
San Diego swaps its No. 2 prospect for a high-velocity arm in the final hours, but Mize's injury history and groin troubles this season complicate the upside.
The Padres pulled the trigger on a substantial rotation upgrade in the final moments of the Trade Deadline on Monday, acquiring right-hander Casey Mize and utility infielder Gage Workman from Detroit in exchange for prospects Kash Mayfield (San Diego's No. 2 prospect) and rookie left-hander Jackson Wolf. It's a clear commitment to win now—the kind of deal you make when you believe your window is open and starting pitching is the bottleneck.
Mize's trajectory offers real upside for a Padres rotation that needed reinforcement. The 2018 first overall pick spent the better part of two years recovering from Tommy John surgery and a back procedure that derailed his early career arc, but he's engineered a genuine resurgence since returning to health. Last year's All-Star campaign (14-6, 3.87 ERA) evolved into something more dangerous in 2026: a 2.70 ERA over his starts entering the deadline, paired with an 8.8 K/9 rate that signals he's rediscovered his strikeout potential. His splitter—a wipeout pitch in college that had lost its edge—has regained bite. His fastball plays up with increased induced vertical break despite a slight velocity dip, and he's rounded out his arsenal with both a slider and slurve. That's a genuinely three-pitch mix capable of generating whiffs at volume.
The durability concern is real and priced nowhere near its true weight. Mize has managed just two separate injured-list stints and a shortened start against the Angels on July 19 because of a persistent groin injury that has shadowed his entire 2026 campaign. Groin issues have a nasty habit of lingering—they're not clean breaks you come back from; they're the kind of thing that resurfaces under fatigue or when a pitcher ramps up intensity down the stretch. The fact that he's played through it this season and still posted a 2.70 ERA tells you the stuff is real, but it also means the Padres are betting he can handle a full postseason gauntlet without another flare-up. That's not a bet you want to stake heavy strikeout prop volume on through September and October.
For bettors, Mize's strikeout prop enters an interesting window. His 8.8 K/9 baseline is legitimate and durable across his last 28 starts; books will likely hang a K prop in the 7.5-to-8.5 range depending on opponent matchup. Early September starts against weaker lineups (when Mize hasn't been heavily used) should offer good value on the over, especially in neutral or pitcher-friendly parks. But fade that line late in the month or if there's any public reporting about the groin tightening. The edge exists now because the market will price his arrival as a flat upgrade; it won't immediately bake in the injury recurrence risk or the compressed recovery time between starts in September stretch runs.
The Padres' pitching depth just got materially better. Whether Mize stays healthy enough to deliver that value in October is the real prop bet beneath the surface.